symbol,statement_type,period_end,line_item,value
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,19740000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-9260000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-6110000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,End Cash Position,5730000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,8350000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,-90000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-2530000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-22980000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-2620000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-10830000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-9260000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,-3970000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Payments,-3970000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-5290000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-5290000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-5400000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,200000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,330000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,450000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-120000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-5930000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,180000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-6110000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,25850000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-6030000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-4810000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,940000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-2780000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-2620000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-350000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,2320000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,20000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,7950000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation,7950000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-170000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-150000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-10000000.0
TORNTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,26730000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,28330000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-13690000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-4330000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,End Cash Position,8350000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,5080000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,80000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,3190000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-27790000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-3710000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-10150000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-13690000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-1330000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Payments,-1330000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-12360000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-12360000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1680000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,130000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,1180000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,1180000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-2990000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,1340000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-4330000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,32660000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-4980000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,4180000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-180000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Payable,4140000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-490000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,710000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,2540000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,70000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,8080000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,5429200000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation,8080000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-180000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-570000000.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
TORNTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,23520000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,17941900000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-9718400000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,13950000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-5739400000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,End Cash Position,5085300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,588300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,3984000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,211200000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,301800000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,773600000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-3030200000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-8630400000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,12651900000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,8420300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Payments,
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,4231600000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-9718400000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,13950000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-24153100000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,129000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-129800000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,474000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-603800000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,-20000000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,-20000000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-4152300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,1587100000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-5739400000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,23681300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-3980700000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-182000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,931100000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-580200000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,2557100000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-3090000000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,3186600000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,22700000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,7020300000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,4765600000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation,2254700000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-195100000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-491500000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-216200000.0
TORNTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,18471600000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,16004200000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-10329800000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,0.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-2025700000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,End Cash Position,3984000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,5725600000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,5300000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-1746900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-17810500000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-2577200000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-6768900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-8143400000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,2186400000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Payments,
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-10329800000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-10329800000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,0.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-1966300000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,72400000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-80900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,267000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-347900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,0.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,0.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-1957800000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,67900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-2025700000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,18029900000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-4210200000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-3518500000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-653000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Payable,-3923700000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,2188800000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-1130600000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,7326100000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,9000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,6619300000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,4157000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation,2462300000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-101400000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-364000000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,8200000.0
TORNTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,12259100000.0
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,8950000000.0
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,-3380000000.0
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Payments,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,8950000000.0
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,4206000000.0
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
TORNTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
